Loading
Latest filing published 10 Apr 2026 for MOLOGEN Lifescience AG, €150k. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Matthias Bäumler is a declared insider of MOLOGEN Lifescience AG (board member), with filings sourced from BaFin. We count 2 filings, every one of them for a trade on 7 April 2026.
The open-market record is one-sided, with 2 purchases worth €300k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 10 April 2026, the filings show an open-market purchase worth €150k in MOLOGEN Lifescience AG. This summary is built from BaFin disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations